The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

A trial is set to begin on Wednesday in Chicago in a case brought by four families who allege that baby ​formula made by ...

Abbott is an innovator and has made plenty of highly successful breakthroughs. That's what it did with its FreeStyle Libre ...

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to ...

Abbott Labs is looking to raise about $20 billion from a bond sale to help fund its acquisition of Exact Sciences, marking ...

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with a modest 0.2% move over ...

The stock's fall snapped a three-day winning streak.

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, but did not ...

Abbott stock skidded Wednesday after the S&P 500 health giant missed the Street's third-quarter sales forecast, but met earnings expectations and reiterated its full-year guidance. The sales miss is ...

Shares of Abbott Laboratories (NYSE: ABT) recently plunged after the company announced its fourth-quarter results. Over the trailing 12 months, the stock is down 16%. Some might choose to stay away ...

Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...